| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |